Form 4: Disc Medicine Director William White Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director William Richard White exercised stock options and sold shares of Disc Medicine, Inc. (IRON) on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 1, 2024, William Richard White, a director of Disc Medicine, Inc. (IRON), executed a transaction involving the company's stock.
• White exercised a stock option to acquire 201 shares at a price of $9.86 per share.
• Concurrently, White sold 201 shares acquired through the option exercise and an additional 169 shares, 40 shares, 50 shares and 79 shares in multiple transactions at weighted average prices of $49.0275, $50.4513, $51.51 and $52.5318 respectively.
• These transactions were executed under a pre-existing Rule 10b5-1 trading plan adopted on December 13, 2023.
• Following these transactions, White directly owns 2,206 derivative securities and no common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions under a pre-existing plan, with no indication of significant positive or negative developments.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can provide transparency and reduce concerns about insider trading.

Negatives

• The sale of shares by a director could be perceived negatively by some investors, although it is part of a pre-planned strategy.

Risks

• Market reaction to the director's stock sales could introduce short-term price volatility.
• Changes in the company's performance or outlook could affect the value of the remaining derivative securities held by the director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan is a common practice to allow insiders to sell shares without concerns about insider trading, as the plan is established in advance.

Comparison to Industry Standards

• The transactions are typical for directors who receive stock options as part of their compensation.
• The use of a 10b5-1 trading plan is a standard practice among corporate insiders to manage their stock holdings.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the director's sale of shares, but the pre-planned nature of the sales mitigates concerns.

Key Dates